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Apoptosis in parathyroid hyperplasia of patients with primary and secondary (28) hyperparathyroidism is a frequent
or secondary uremic hyperparathyroidism. complication of chronic renal failure [2, 3].
Background. Chronic oversecretion of parathyroid hormone The excessive parathyroid hormone (PTH) secretion
(PTH) is associated with parathyroid hyperplasia, reflecting a
of 18 parathyroid adenoma has been shown to be associ-disturbed balance between cell proliferation and apoptosis.
ated with increased parathyroid cell growth, which isThis study addressed the unsolved issue of apoptosis in hyper-
parathyroidism. monoclonal in nature [4]. The PRAD1/cyclin D1 onco-
Methods. Parathyroid glands from 19 patients with primary gene, which is abnormally placed under the influence of
(18) and 11 patients with secondary (28) uremic hyperparathy- the regulatory region of the PTH gene [5], as well as
roidism, as well as 13 normal parathyroid glands, were exam- various deletions of tumor suppressor genes [6], couldined. Apoptosis was evaluated by terminal deoxynucleotidyl
be responsible in at least a subgroup of patients with 18transferase (Tdt)-mediated dUTP nick end-labeling assay
adenoma. Diffuse parathyroid hyperplasia in 28 uremic(TUNEL). Because the apoptotic process is regulated by sev-
eral oncoproteins, the expression of Bcl-2 and Bax was ana- hyperparathyroidism has been shown to be due to sev-
lyzed by immunohistochemistry. eral factors, including phosphate retention, calcium de-
Results. The numbers of apoptotic cells in 18 parathyroid ficiency, and disturbed vitamin D metabolism [2, 7–11].
adenoma (0.99 6 0.03 per 1000 cells, mean 6 se, P , 0.009)
In case of severe and prolonged hyperparathyroidism, itand 28 parathyroid hyperplasia (1.20 6 0.54 per 1000 cells, P ,
may exhibit a monoclonal growth pattern, instead of0.005) were significantly higher than in normal parathyroid
the expected polyclonal pattern [12]. Possible underlyingtissue (0.13 6 0.06 per 1000 cells). Light microscopy examina-
tion of hyperplastic parathyroid tissue from a uremic patient somatic mutations of specific suppressor or enhancer
showed the presence of nuclei with dense chromatin character- genes as yet await elucidation.
istic of apoptosis. Bcl-2 staining was strong in normal tissues The precise mechanisms involved in the control of
but weak or negative in several sections of 18 and 28 hyperpara-
parathyroid cell growth, division and death, and hencethyroid tissues, mostly in nodular areas. Bax staining was homo-
in the regulation of parathyroid size are unknown atgeneous in normal tissue but patchy in several hyperplastic
present. The recent introduction of new cellular andtissues.
Conclusion. These results suggest that hyperparathyroidism molecular biology tools allow a more precise examina-
is associated with a compensatory increase in apoptosis, possi- tion than previously of the relative contribution of prolif-
bly favored by a diminished Bcl-2/Bax ratio. This renders highly eration and apoptosis to excessive parathyroid gland size.improbable the hypothesis that parathyroid hyperplasia is due
Depressed apoptosis can promote hyperplasia and can-to a decreased rate of apoptosis.
cer development by both allowing accumulation of divid-
ing cells and obstructing removal of genetic variants with
enhanced malignant potential [13].Primary (18) hyperparathyroidism is a common endo-
The possible involvement of apoptosis in benign orcrine disorder, particularly in the older population [1],
malignant human parathyroid hyperplasia is still uncer-
tain, in contrast to studies demonstrating a dysregulation
of apoptosis in cancer of the thyroid [14], the adrenalKey words: hyperparathyroidism, apoptosis, TUNEL, oncoproteins,
uremia. gland [15], and the digestive tract [16], and in inflamma-
tory hyperplastic diseases such as rheumatoid arthritisReceived for publication May 27, 1999
[17]. The reason is probably that apoptosis is a rare eventand in revised form September 8, 1999
Accepted for publication September 9, 1999 in normal or hyperplastic parathyroid tissue, which has
made its detection impossible thus far in experimentalÓ 2000 by the International Society of Nephrology
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chronic renal failure [8, 18] because of technical difficul- HCl 0.01 N, pH 2.0, for five minutes at 378C. Then, 40
ties. Its recent assessment in human parathyroid tissues to 50 mL of TUNEL reaction mixture (10 3 Tdt 50 mL,
led to findings of very high apoptotic figures (abstract; 1 3 nucleotide mixture 550 mL; in situ cell death detec-
Zhang et al, J Am Soc Nephrol 7:1504, 1996) [19], which tion kit, AP; Boehringer Mannheim, Meyl, France) was
may also be due to methodological problems. added to each section, covered with a coverslip, and
Therefore, the present study was designed to re-exam- incubated in a humidified chamber at 378C for 60 min-
ine the rate of apoptosis in parathyroid tissue and its utes. Subsequently, 50 mL Converter-AP (antifluorescein
possible role in the parathyroid hyperplasia of 18 and 28 antibody Fab fragment from sheep, conjugated with al-
hyperparathyroidism. We used a refined technique of kaline phosphatase) were applied to each specimen, and
terminal deoxynucleotidyl transferase (Tdt)-mediated the slides were incubated for 30 minutes at 378C in a
dUTP nick end labeling assay (TUNEL) to detect apop- humidified chamber. The reaction was revealed by add-
totic cells and immunohistochemistry to determine the ing 100 mL substrate solution (NBT-BICP; Boehringer
expression of the apoptosis-regulatory oncoproteins Mannheim) for 10 minutes at room temperature. The
Bcl-2, Bax, Fas, and p53. slides were washed with PBS and mounted with Aquatex
(Merck, Nogent, France). The developing reagent gave
a dark color for positive signals.METHODS
For positive control, sections were incubated with 500Parathyroid tissue
mg/mL DNAse I (Boehringer Mannheim). After a 10-Parathyroid tissue was collected at the time of surgery
minute incubation at room temperature, the slides werefrom patients with 18 hyperparathyroidism (19 cases)
extensively washed with PBS and continued to be pro-and 28 hyperparathyroidism (11 cases). The mean 6 sem
cessed through DNA nick end labeling. As a negativeplasma total calcium level was 2.85 6 0.09 and 2.56 6
control, the tissue sections were incubated with TUNEL0.06 mmol/L, respectively, and the plasma intact PTH
reaction mixture in the absence of Tdt [15].level was 131 6 75 and 1122 6 315 pg/mL, respectively.
The number of positive cells (black nuclei correspond-Normal parathyroid tissue was harvested from patients
ing to marked condensations of nuclear chromatin) waswho underwent cervical surgery for thyroid diseases such
randomly determined for all tissues under light micro-as goiter and cancer (13 cases). Tissue sampling was
scope (Leica, France). It has been shown previously thatapproved by the local review board. The postsurgical
a positive TUNEL pattern seen as black spots closelyspecimens were immediately placed into RPMI 1640 me-
correlated with the morphologic prevalence of apoptosisdium (Life Technologies, Cergy, France) on ice and
transferred to the laboratory. On arrival, part of the in fast-growing tissues [20]. Three independent observers
specimens was used for DNA extraction, and other por- counted each 10 high-power fields with approximately
tions were deep frozen at 2808C. 200 cells per field, at 3400 magnification. Thereafter,
their estimations of the apoptotic numbers were aver-
Light microscopy aged.
Fractions of parathyroid tissue from a uremic patient
with 28 hyperparathyroidism were fixed in 2% glutaral- Immunohistochemistry
dehyde with phosphate buffer for one hour, postfixed in Parathyroid tissue sections (5 mm) were fixed in 100%
2% osmium tetroxide for one hour, dehydrated in an acetone for 10 minutes. For Bcl-2, Bax, Fas, and p53
alcohol series, and then embedded in Epon resin. Semi- sections were processed using the avidin-biotin peroxi-
thin sections were made, colored with toluidine blue, dase complex method developed by Hsu, Raine, and
and studied in light microscopy. Marked condensations
Fanger (kit LSAB2; HRP Dako, Glostrup, Denmark)
of nuclear chromatin were considered to represent apop-
[21]. The slides were exposed to the first antibody di-tosis.
rected against either Bcl-2 (clone 124; Dako), Bax (clone
I 19; Santa Cruz Chemical, Santa Cruz, CA, USA), FasTdt-mediated dUTP nick end labeling assay
(clone N 18, Santa Cruz Chemical), or p53 (clone DO-7;Fragmented DNA was detected in cell nuclei using a
Dako) overnight at 48C. The sections were rinsed andmodification of previously described methods [17, 20].
then incubated with biotinylated link antibody and per-Frozen sections of parathyroid tissue (10 mm thick) were
oxidase-labeled streptavidin. The reaction was revealedfixed with a freshly prepared paraformaldehyde solution
by substrate chromogen solution (AEC; Dako). The de-[4% in phosphate-buffered saline (PBS), pH 7.4] for 30
gree of immunoreactivity was semiquantitatively deter-minutes at room temperature. The slides were washed
mined by three independent observers as follows: (2)with PBS for 20 minutes at room temperature and then
negative, (6) weakly positive, (1) moderately positive,incubated in permeabilization solution containing 10
mg/mL pepsin (Sigma, Sequentin Fallavier, France) in and (11) strongly positive.
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Statistical analysis parathyroidism and from seven uremic patients with 28
hyperparathyroidism, as compared with normal parathy-Estimations of apoptotic numbers by TUNEL tech-
roid gland tissues sampled from seven subjects. The semi-nique made by three observers were compared using the
quantitative evaluation of the percentage of Bcl-2–positiveanalysis of variance (ANOVA) test, which allowed us
parathyroid cells revealed positive to strongly positive,to ascertain that estimations did not differ significantly.
diffuse staining patterns in the seven normal tissues stud-Then apoptotic figures were averaged and first analyzed
ied. In contrast, the intensity of immunostaining in bothby the Kruskal–Wallis test, followed by the Mann and
18 and 28 hyperparathyroid tissues were not homoge-Whitney U-test. Results are expressed as means 6 sem.
neous from one sample to the other, with entirely nega-
tive staining in nodular areas. Figure 4 reveals focal de-
RESULTS crease of Bcl-2 staining in nodular area, compared with
Light microscopy diffusely hyperplastic area, of parathyroid tissue from a
patient with 28 hyperparathyroidism.The study of semithin sections of parathyroid gland
from a uremic patient with 28 hyperparathyroidism al- The semiquantitative assessment of the percentage of
lowed the visualization of an extensive tissue area. Figure Bax-positive parathyroid cells revealed moderately posi-
1A shows a large zone of parathyroid cells having pre- tive, homogeneous staining patterns in all seven normal
dominantly a normal aspect with nuclei composed by tissues studied. In contrast, the intensity of immunostain-
sparse and dense clumps of chromatin. In addition, this ing in both 18 and 28 hyperparathyroid tissues was again
zone contains several cells being in various phases of variable from tissue to tissue, with nodular areas staining
mitosis (Fig. 1B), and other cells with nuclei having a strongly positive in two cases of 28 hyperparathyroidism
homogeneous, extremely dense chromatin characteristic but negative in one case of 18 adenoma. In some tissue
of apoptosis (Fig. 1C). sections of patients with 28 hyperparathyroidism, Bcl-
2–negative but Bax-positive staining was observed in
In situ detection of DNA fragmentation nodular areas compared with adjacent hyperplastic para-
Analysis of parathyroid tissue by TUNEL technique thyroid tissue on sequential slices (data not shown). The
revealed a distinct pattern of nuclear staining between Bcl-2/Bax ratio was frequently, although not always, de-
positive cells (distinct black spots) and negative cells creased.
(diffuse purple aspect) (Fig. 2). Figure 2A shows a typical Fas staining of parathyroid cells was moderately posi-
feature of normal parathyroid tissue with one apoptotic tive and homogeneous in all seven normal tissues stud-
cell per high-power field. Figure 2 B and C represent ied, whereas the intensity of immunostaining was nega-
characteristic findings in patients with 28 hyperparathy- tive in 18 hyperparathyroid tissues in most instances but
roidism, respectively, containing either one or several variable in 28 hyperparathyroid tissues. Immunostaining
positive cells. Figure 2D shows a representative feature
for p53 proved to be negative in all parathyroid tissuesof 18 hyperparathyroidism with several positive cells. It
studied (data not shown).must be noted that there was frequently a patchy increase
in TUNEL-positive cells in both 18 and 28 hyperparathy-
roidism. Figure 2 E and F are negative (absence of Tdt) DISCUSSION
and positive (DNAse treatment) controls for TUNEL The first finding of this study was the identification of
reaction, respectively. a low prevalence of apoptosis in normal human parathy-
The quantitative analysis of TUNEL findings revealed roid tissue, with a mean frequency of approximately 1
a significant increase in the number of positive apoptotic
apoptotic figure per 10,000 cells. Such a low prevalencecells (expressed per 1000 cells) in parathyroid tissues
was not unexpected. Two other groups have been unablefrom 19 patients with 18 hyperparathyroidism and 11
to identify apoptotic figures in parathyroid tissue [8, 18].patients with 28 hyperparathyroidism, respectively, com-
Very low parathyroid cell birth and death rates havepared with 13 normal parathyroid tissues. The mean
long been suspected on the basis of indirect evidencenumber of apoptotic figures per 1000 parathyroid cells
[22]. Because parathyroid cell proliferation and pro-for each tissue group is shown in Figure 3. It was 0.13 6
grammed death must be in equilibrium under physiologi-0.06‰ in normal glands, 0.99 6 0.03‰ in 18 hyperpara-
cal conditions, given the maintenance of a constant organthyroidism, and 1.20 6 0.54‰ in 28 hyperparathyroidism.
size over time in adult life, it is interesting to compareWhereas the means of apoptotic cell counts did not differ
our apoptotic figures with proliferation rates in normalbetween the latter two, they were both significantly
human parathyroid glands. These apoptotic figures arehigher than those of normal tissue.
of a similar order of magnitude as mean cell proliferation
Expression of Bcl-2, Bax, Fas, and p53 proteins rate found by us in ex vivo normal parathyroid gland
samples (data not shown), but approximately two timesTable 1 shows Bcl-2, Bax, and Fas immunoreactivity
in parathyroid tissues from six patients with 18 hyper- higher than in the post mortem tissues studied by Parfitt’s
Fig. 1. Light microscopy evidence of apoptosis. Light microscopy examination of semithin sections of parathyroid tissue from a uremic patient
with secondary (28) hyperparathyroidism shows a large zone of parathyroid cells having predominantly a normal aspect with nuclei composed by
sparse and dense clumps of chromatin, whereas few cells have nuclei exhibiting either mitotic (b) or apoptotic (!) aspect (A; 3500). Greater
magnification of one zone of this field shows various types of nuclei. The majority look morphologically normal whereas a few exhibit an aspect
of mitosis (b; B; 31200). Another area of this zone shows several nuclei having a homogeneous, extremely dense chromatin characteristic of
apoptosis (!; C; 31200).
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Fig. 2. Apoptotic cells in parathyroid tissues revealed by TUNEL assay. Nuclear staining of positive cells is evidenced by distinct black spots,
whereas negative cells have a diffuse purple aspect. (A) Typical feature of normal parathyroid tissue with one apoptotic cell per high power field.
(B and C ) Characteristic findings in patients with 28 hyperparathyroidism, respectively, containing one and five positive cells, respectively. (D)
Representative feature of 18 hyperparathyroidism with three positive cells. (E and F ) Negative (absence of Tdt) and positive (DNAse treatment)
controls for TUNEL reaction, respectively (3400).
group, using the Ki-67 labeling index [23]. However, that the time period of the apoptotic process is much
shorter than that of mitosis. Therefore, in a given tissue,Abbona et al, who used Ki-67 antiserum [24], and Yama-
guchi, Yachiku, and Morikawa using proliferating cell the prevalence of cells undergoing programmed death
should generally be lower than that of cells undergoingnuclear antigen (PCNA) antiserum [25] found much
higher proliferation figures in ex vivo tissues by yet an- division, and the calculation of true birth and death rates
relies on unverified assumptions regarding the respectiveother order of magnitude. Ki-67 and PCNA are cell
cycle-associated antigens, the expression of which allows time periods of cell division and apoptosis in parathyroid
tissue. Alternatively, differences may also be due to dif-the estimation of cell proliferative activity.
Differences in estimations of proliferation and apopto- fering modes of tissue conservation at the time of sam-
pling, for instance, postmortem versus in vivo sampling.sis rates can at least partially be explained by the fact
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namely Bcl-2, Bax, and p53, compared with their homo-
geneous expression in normal control tissue, as assessed
by semiquantitative immunohistochemistry. Bcl-2 pro-
tects against cell death, whereas bax, fas, and p53 pro-
mote apoptosis. Immunostaining of Bcl-2 was weak and
occasionally negative, especially in nodular areas of 18
and 28 hyperparathyroid tissues compared with moderate
to strong staining in all normal tissues studied. The ex-
pression of Bax was also homogeneously positive in all
normal tissues but again patchy in the hyperplastic tis-
sues, with nodular areas staining intensely positive in
two cases of 28 hyperparathyroidism, but negative in one
case of 18 parathyroid adenoma. Thus, the Bcl-2/Bax
ratio was frequently, although not always, decreased.Fig. 3. Percentage of apoptotic cells in sections of parathyroid tissue.
Number of apoptotic (TUNEL positive) cells per 1000 parathyroid A decrease in this ratio has been found to favor the
cells in tissues from normal human control subjects, and in tissues development of programmed cell death, although many
from patients with 18 hyperparathyroidism and 28 hyperparathyroidism.
other factors are equally involved in the regulation ofData are expressed as means 6 sem. *P , 0.009, 18 hyperparathyroid-
ism (N 5 19) vs. normal (N 5 13); **P , 0.005, 28 hyperparathyroidism apoptosis [27].
(N 5 11) vs. normal. Fas staining of parathyroid cells was moderately posi-
tive and homogeneous in all normal tissues, whereas the
intensity of immunostaining was negative in 18 hyperpar-
athyroid tissues in most instances, but variable in 28 hyp-The second finding of this study was a significant in-
erparathyroid tissues. No p53 expression was found. Thecrease in the apoptotic rate in parathyroid tissues of
latter negative finding is in accord with the observationpatients with 18 and 28 hyperparathyroidism, respectively.
by others of a generally absent p53 immunostaining inWhereas we were able to demonstrate an enhanced rate
normal or hyperplastic parathyroid tissue [28, 29].of apoptosis in the majority of cases with either type of
Obviously, semiquantitative immunohistochemical as-parathyroid hyperplasia using the highly sensitive TUNEL
sessment has inherent limitations with respect to quanti-technique, evidence of apoptosis (“DNA ladder”) was
tation, which is made even more difficult by an unevenobtained in only one of six cases of 18 and one of five
distribution of proliferating and dying cells across patho-cases of 28 hyperparathyroidism using the less sensitive
logic tissue.method of DNA gel electrophoresis (data not shown).
Our observation of parathyroid tissue apoptosis using
The apparent difference between the two results might
TUNEL technique is in apparent contrast to two recent
also be in part due to focal enhancement of apoptosis
studies using same technique. They were done in experi-
in parathyroid hyperplasia, as suggested by the focal mental animals in which apoptotic parathyroid cells
accumulation of TUNEL-positive cells in several hyper- could neither be detected in normal rats, nor rats with
plastic tissues from patients with either 18 or 28 hyper- chronic renal failure or rats maintained on a high-phos-
parathyroidism. The number of TUNEL-positive, apop- phate diet [8, 18]. On the other hand, in a third study,
totic figures per 104 cells was approximately 10 to 50 apoptotic cells were found using TUNEL technique in
times lower than that recently reported for human 18 13 of 15 remnants of normal human parathyroid tissues
parathyroid adenoma by Wang et al [19]. Our apoptotic outside a 18 adenoma [19]. The reason for the discrep-
figures were not in agreement with proliferative figures ancy between these studies and ours is currently unclear.
found by others in adenomatous parathyroid tissue by There may be several explanations. First, technical prob-
approximately one order of magnitude higher than Par- lems probably play a major role because the optimal
fitt, Wang, and Palnitkar [26], but at least 20 to 40 times preparation of tissues for the detection of true apoptotic
lower than the numbers of Ki-67–positive and PCNA- cells is difficult and cumbersome, especially in the case
positive cells, respectively, found in hyperplastic and/or of tissues with a low proliferation rate [30]. Thus, in a
adenomatous parathyroid tissues by two other groups preliminary study (abstract; Zhang et al, J Am Soc
using comparable techniques to estimate proliferation Nephrol 7:1504, 1996), we found apoptotic numbers that
[24, 25]. Of note, in the four latter studies, paraffin- were higher by one order of magnitude than our current
embedded tissue samples were used, whereas we used numbers, similar to the findings by Wang et al [19]. Sec-
deep-frozen tissue samples. ond, in experimental animals, the induction time of para-
The third finding of our study was the disturbed, thyroid hyperplasia by chronic renal failure or a high-
patchy expression in parathyroid hyperplasia of three phosphate diet clearly is always much shorter, and the
severity of 28 hyperparathyroidism is less marked than inoncoproteins involved in the regulation of apoptosis,
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Table 1. Summary of immunostaining for Bcl-2, Bax and Fas protein in normal parathyroid tissue and in hyperplastic tissue from patients
with primary (18; adenoma) or secondary (28) uremic hyperparathyroidism
Parathyroid tissue Bcl-2 Bax Fas
Normal 11 N54 1 N57 6 N57
(N57) 1 N53
18 Hyperparathyroidism 1 N53 11 N51 2 N53
(N56) 1 N53
6 N51
nodular areas 2 2 6
with diffuse areas 1 N53 1 N51 2 N53
28 Hyperparathyroidism 11 N52 11 N52 1 N52
(N57) 6 N52 1 N51 6 N53
2 N51 6 N52
nodular areas 2 11 6
with diffuse areas 1 N52 2 N52 2 N52
Fig. 4. Immunostaining of Bcl-2 in nodular parathyroid hyperplasia. Focal decrease of Bcl-2 staining in tissue section corresponding to nodular
area (lower part) compared with staining in diffusely hyperplastic area (upper part) of parathyroid gland of a patient with 28 hyperparathyroidism
(3400).
patients with advanced parathyroid disease. A prolonged thereby limiting a rapid increase in gland size, at least to
some extent. Fourth, rat parathyroid tissue may exhibit acourse of parathyroid hyperplasia may be required to
accelerate the apoptotic process, allowing the avoidance different propensity than human tissue in accelerating
the apoptotic process in response to hyperplasia.of excessive parathyroid gland growth. Third, a transfor-
mation from polyclonal to monoclonal or multiclonal Light and electron microscopy examination of hyper-
plastic parathyroid tissues allows the detection of mitosesgrowth of parathyroid tissue probably had occurred in
most of the tissues sampled from the dialysis patients only infrequently [22]. The detection of apoptotic num-
bers by these methods is even more difficult. However,[12, 31] and in all patients with 18 adenoma [4], whereas
this almost certainly was not the case in the experimental we found light microscopy evidence of apoptosis in a
patient with severe 28 hyperparathyrodism. This is inanimals. Enhanced apoptosis could be limited to rapidly
growing tissues with benign tumoral growth patterns, keeping with a recent report by Ho¨randner et al, who
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some mapping of DNA rearranged with the parathyroid hormonefound an increased apoptotic rate in autotransplanted
gene in parathyroid adenoma. J Clin Invest 83:2034–2040, 1989
parathyroid tissue with recurrent hyperparathyroidism 6. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A: Genomic
localization of novel candidate tumor suppressor gene loci in hu-in uremic patients, also based on light microscopy exami-
man parathyroid adenomas. Cancer Res 56:599–605, 1996nation [32].
7. Szabo A, Merke J, Beier E, Mall G, Ritz E: 1,25(OH)2 vitaminWhether the increased apoptosis in hyperplastic para- D3 inhibits parathyroid cell proliferation in experimental uremia.
Kidney Int 35:1049–1056, 1989thyroid tissue of uremic patients is linked to the patho-
8. Naveh-Many T, Rahamimov R, Livni N, Silver J: Parathyroid celllogic process per se or represents a more general feature
proliferation in normal and chronic renal failure rats: The effects
of the state of chronic renal failure remains to be seen. of calcium, phosphate, and vitamin D. J Clin Invest 96:1786–1793,
1995In support of the latter, recently it has been shown that
9. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kuro-monocytes cultured from chronic hemodialysis patients
kawa K: Prevention of enhanced parathyroid hormone secretion,
exhibited an elevated degree of apoptosis [33], possibly synthesis and hyperplasia by mild dietary phosphorus restriction
in early chronic renal failure in rats: Possible direct role of phospho-favored by the use of so-called bioincompatible dialysis
rus. Nephron 70:242–248, 1995membranes [34]. It is also possible that both systemic
10. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso
and local factors contribute to an acceleration of pro- A, McDonald PN, Brown AJ: Phosphorus restriction prevents
parathyroid gland growth: High phosphorus directly stimulatesgrammed cell death in parathyroid tissue, such as dis-
PTH secretion in vitro. J Clin Invest 97:2534–2540, 1996turbed vitamin D metabolism and increased cytoplasmic
11. Wang Q, Paloyan E, Parfitt AM: Phosphate administration in-
calcium concentration [30]. creases both size and number of parathyroid cells in adult rats.
Calcif Tissue Int 58:40–44, 1996Taken together, these observations show an increased
12. Arnold A, Brown MF, Uren˜a P, Gaz RD, Sarfati E, Dru¨ekerate of apoptosis in both 18 and 28 uremic hyperparathy-
TB: Monoclonality of parathyroid tumors in chronic renal failure
roidism compared with the very low rate observed in and in primary parathyroid hyperplasia. J Clin Invest 95:2047–2053,
1995normal parathyroid tissue. This finding appears to ex-
13. Carson D, Ribeiro JM: Apoptosis and disease. Lancet 341:1251–clude the theoretical possibility that hyperplasia is due,
1254, 1993
at least in part, to a decrease in apoptosis. The focal or 14. Pilotti S, Collini P, Rilke F, Cattoretti G, Delbo R, Pierotti
M: Bcl-2 protein expression in carcinomas originating from thediffuse decrease in the expression of Bcl-2, together with
follicular epithelium of the thyroid gland. J Pathol 172:337–342,a patchy, sometimes increased expression of Bax in the
1994
hyperplastic parathyroid tissue of at least some patients 15. Sasano H, Imatani A, Shizawa S, Suzuki T, Nagura H: Cell
proliferation and apoptosis in normal and pathologic human adre-with severe 18 or 28 hyperparathyroidism may favor en-
nal. Mod Pathol 8:11–17, 1995hanced apoptosis. The latter may serve to limit excessive
16. Kobayashi M, Watannabe H, Ajioka Y, Yoshida M, Hitomi J,
parathyroid gland growth in case of parathyroid hyper- Asakura H: Correction of p53 protein expression with apoptotic
incidence in colorectal neoplasia. Virchows Arch 427:27–32, 1995plasia.
17. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid
arthritis synovium. J Clin Invest 96:1631–1638, 1995
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